Luo JL - Search Results

1

Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin.

Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL, Cheresh DA, Karin M. Luo JL, et al. Nature. 2007 Apr 5;446(7136):690-4. doi: 10.1038/nature05656. Epub 2007 Mar 18. Nature. 2007. PMID: 17377533

2

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis.

Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, Luo JL, Karin M. Kim S, et al. Among authors: luo jl. Nature. 2009 Jan 1;457(7225):102-6. doi: 10.1038/nature07623. Nature. 2009. PMID: 19122641 Free PMC article.

3

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer.

Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M. Ammirante M, et al. Among authors: luo jl. Nature. 2010 Mar 11;464(7286):302-5. doi: 10.1038/nature08782. Nature. 2010. PMID: 20220849 Free PMC article.

4

IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha.

Maeda S, Chang L, Li ZW, Luo JL, Leffert H, Karin M. Maeda S, et al. Among authors: luo jl. Immunity. 2003 Nov;19(5):725-37. doi: 10.1016/s1074-7613(03)00301-7. Immunity. 2003. PMID: 14614859 Free article.

5

The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4.

Hsu LC, Park JM, Zhang K, Luo JL, Maeda S, Kaufman RJ, Eckmann L, Guiney DG, Karin M. Hsu LC, et al. Among authors: luo jl. Nature. 2004 Mar 18;428(6980):341-5. doi: 10.1038/nature02405. Nature. 2004. PMID: 15029200 Free article.

6

Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression.

Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Luo JL, et al. Cancer Cell. 2004 Sep;6(3):297-305. doi: 10.1016/j.ccr.2004.08.012. Cancer Cell. 2004. PMID: 15380520 Free article.

7

IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

Maeda S, Kamata H, Luo JL, Leffert H, Karin M. Maeda S, et al. Among authors: luo jl. Cell. 2005 Jul 1;121(7):977-90. doi: 10.1016/j.cell.2005.04.014. Cell. 2005. PMID: 15989949 Free article.

8

IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.

Luo JL, Kamata H, Karin M. Luo JL, et al. J Clin Invest. 2005 Oct;115(10):2625-32. doi: 10.1172/JCI26322. J Clin Invest. 2005. PMID: 16200195 Free PMC article. Review.

9

The anti-death machinery in IKK/NF-kappaB signaling.

Luo JL, Kamata H, Karin M. Luo JL, et al. J Clin Immunol. 2005 Nov;25(6):541-50. doi: 10.1007/s10875-005-8217-6. J Clin Immunol. 2005. PMID: 16380818 Review.

10

IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells.

Cao Y, Luo JL, Karin M. Cao Y, et al. Among authors: luo jl. Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15852-7. doi: 10.1073/pnas.0706728104. Epub 2007 Sep 21. Proc Natl Acad Sci U S A. 2007. PMID: 17890319 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters